Verotoxin (Shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: Possible implications for the hemolytic uremic syndrome

Journal of the American Society of Nephrology

Volumn 15, Issue 9, 2004, Pages 2334-2343

  Bitzan, Martin ^a,b   Bickford, Brandi B ^a   Foster, Gregory H ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEME; HEME OXYGENASE 1; HEMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SHIGA TOXIN; VEROTOXIN;

ARTICLE; CELL DAMAGE; CELL GROWTH; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; ENZYME DEGRADATION; ESCHERICHIA COLI; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; NEPHROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION;

EID: 4344649464     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000138547.51867.43     Document Type: Article

References (50)

1. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI: The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342: 1930-1936, 2000
2. Siegler RL: The hemolytic uremic syndrome. Pediatr Clin North Am 42: 1505-1529, 1995
3. Brandt JR, Fouser LS, Watkins SL, Zelikovic I, Tarr PI, Nazar-Stewart V, Avner ED: Escherichia coli O157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. J Pediatr 125: 519-526, 1994
4. Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DW, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH: Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: A randomized controlled trial. JAMA 290: 1337-1344, 2003
5. Dundas S, Todd WT, Stewart AI, Murdoch PS, Chaudhuri AK, Hutchinson SJ: The central Scotland Escherichia coli O157:H7 outbreak: Risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 33: 923-931, 2001
6. O'Loughlin EV, Robins-Browne RM: Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect 3: 493-507, 2001
7. Sandvig K, Grimmer S, Lauvrak SU, Torgersen ML, Skretting G, van Deurs B, Iversen TG: Pathways followed by ricin and Shiga toxin into cells. Histochem Cell Biol 117: 131-141, 2002
8. Uchida H, Kiyokawa N, Horie H, Fujimoto J, Takeda T: The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatr Res 45: 133-137, 1999
9. Kaneko K, Kiyokawa N, Ohtomo Y, Nagaoka R, Yamashiro Y, Taguchi T, Mori T, Fujimoto J, Takeda T: Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome. Nephron 87: 182-185, 2001
10. Taguchi T, Uchida H, Kiyokawa N, Mori T, Sato N, Horie H, Takeda T, Fujimoto J: Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int 53: 1681-1688, 1998
11. Pijpers AH, van Setten PA, van den Heuvel LP, Assmann KJ, Dijkman HB, Pennings AH, Monnens LA, van Hinsbergh VW: Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol 12: 767-778, 2001
12. Bitzan M, te Loo DM: Interaction of Shiga toxin with endothelial cells. Methods Mol Med 73: 243-262, 2003
13. Bitzan MM, Wang Y, Lin J, Marsden PA: Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J Clin Invest 101: 372-382, 1998
14. Foster GH, Armstrong CS, Sakiri R, Tesh VL: Shiga toxin-induced tumor necrosis factor alpha expression: Requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases. Infect Immun 68: 5183-5189, 2000
15. Karpman D, Hakansson A, Perez MT, Isaksson C, Carlemalm E, Caprioli A, Svanborg C: Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: In vivo and in vitro studies. Infect Immun 66: 636-644, 1998
16. Te Loo DM, Monnens LA, van den Heuvel LP, Gubler MC, Kockx MM: Detection of apoptosis in kidney biopsies of patients with D+ hemolytic uremic syndrome. Pediatr Res 49: 413-416, 2001
17. Richardson SE, Karmali MA, Becker LE, Smith CR: The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19: 1102-1108, 1988
18. Sassa S, Shibahara S: Disorders of heme production and catabolism. In: Blood. Principles and Practice of Hematology, edited by Handing RI, Lux IV SE, Stossel TP, Philadelphia, Lippincott Williams & Wilkins, 2003, pp 1435-1501
19. Bunn HF, Jandl JH: Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem 243: 465-475, 1968
20. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G: Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887, 2002
21. Goldstein L, Teng ZP, Zeserson E, Patel M, Regan RF: Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J Neurosci Res 73: 113-121, 2003
22. Hebbel RP, Eaton JW: Pathobiology of heme interaction with the erythrocyte membrane. Semin Hematol 26: 136-149, 1989
23. Balla J, Balla G, Jeney V, Kakuk G, Jacob HS, Vercellotti GM: Ferriporphyrins and endothelium: A 2-edged sword-Promotion of oxidation and induction of cytoprotectants. Blood 95: 3442-3450, 2000
24. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, Figdor CG: Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802-1811, 2001
25. Zhang X, Fujii H, Matera KM, Migita CT, Sun D, Sato M, Ikeda-Saito M, Yoshida T: Stereoselectivity of each of the three steps of the heme oxygenase reaction: Hemin to meso-hydroxyhemin, meso-hydroxyhemin to verdoheme, and verdoheme to biliverdin. Biochemistry 42: 7418-7426, 2003
26. Maines MD: The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997
27. Soares MP, Usheva A, Brouard S, Berberat PO, Gunther L, Tobiasch E, Bach FH: Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid Redox Signal 4: 321-329, 2002
28. Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J: The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 156: 1527-1535, 2000
29. Hill-Kapturczak N, Chang SH, Agarwal A: Heme oxygenase and the kidney. DNA Cell Biol 21: 307-321, 2002
30. Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49: 314-326, 1996
31. Nath KA, Grande JP, Haggard JJ, Croatt AJ, Katusic ZS, Solovey A, Hebbel RP: Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158: 893-903, 2001
32. Ishitoya S, Kurazono H, Nishiyama H, Nakamura E, Kamoto T, Habuchi T, Terai A, Ogawa O, Yamamoto S: Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice. J Urol 171: 1309-1313, 2004
33. Eisenhauer PB, Chaturvedi P, Fine RE, Ritchie AJ, Pober JS, Cleary TG, Newburg DS: Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun 69: 1889-1894, 2001
34. Willingham MC: Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 47: 1101-1110, 1999
35. Richardson SE, Rotman TA, Jay V, Smith CR, Becker LE, Petric M, Olivieri NF, Karmali MA: Experimental verocytotoxemia in rabbits. Infect Immun 60: 4154-4167, 1992
36. Siegler RL, Pysher TJ, Tesh VL, Taylor FB, Jr.: Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome. J Am Soc Nephrol 12: 1458-1467, 2001
37. Hill-Kapturczak N, Sikorski E, Voakes C, Garcia J, Nick HS, Agarwal A: An internal enhancer regulates heme- and cadmium-mediated induction of human heme oxygenase-1. Am J Physiol Renal Physiol 285: F515-523, 2003
38. Beutler E: Production and destruction of erythrocytes. In: Williams Hematology, edited by Beutler E, Coller BS, Lichtman MA, Kipps TJ, Seligsohn U. New York, McGraw-Hill, 2001, pp 355-368
39. Bunn HF, Jandl JH: The renal handling of hemoglobin. II. Catabolism. J Exp Med 129: 925-934, 1969
40. Grinshtein N, Bamm VV, Tsemakhovich VA, Shaklai N: Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. Biochemistry 42: 6977-6985, 2003
41. Dhar GJ, Bossenmaier I, Cardinal R, Petryka ZJ, Watson CJ: Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission. Acta Med Scand 203: 437-443, 1978
42. Graca-Souza AV, Arruda MA, de Freitas MS, Barja-Fidalgo C, Oliveira PL: Neutrophil activation by heme: Implications for inflammatory processes. Blood 99: 4160-4165, 2002
43. Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, Balla G: Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 18[Suppl 5]: v8-v12, 2003
44. Abraham NG, Scapagnini G, Kappas A: Human heme oxygenase: Cell cycle-dependent expression and DNA microarray identification of multiple gene responses after transduction of endothelial cells. J Cell Biochem 90: 1098-1111, 2003
45. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999
46. Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 94: 10925-10930, 1997
47. Dennery PA, Spitz DR, Yang G, Tatarov A, Lee CS, Shegog ML, Poss KD: Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest 101: 1001-1011, 1998
48. Gonzalez-Michaca L, Farrugia G, Croatt AJ, Alam J, Nath KA: Heme: A determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol 286: F370-F377, 2004
49. Perrella MA, Yet SF: Role of heme oxygenase-1 in cardiovascular function. Curr Pharm Des 9: 2479-2487, 2003
50. Wagner M, Cadetg P, Ruf R, Mazzucchelli L, Ferrari P, Redaelli CA: Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. Kidney Int 63: 1564-1573, 2003